Filtered By:
Condition: Pain
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 1735 results found since Jan 2013.
The most common gastrointestinal alterations in patients with post-COVID syndrome
CONCLUSION: We identified female gender, obesity, cardiovascular diseases, cancer, hypertension and diabetes as major risk factors of post-COVID syndrome. Vaccinated status may prevent post-COVID gastrointestinal symptoms. Orv Hetil. 2023; 164(31): 1206-1212.PMID:37543972 | DOI:10.1556/650.2023.32839
Source: Orvosi Hetilap - August 6, 2023 Category: General Medicine Authors: Kata Angyal Anna Mandula Tajthy B álint Drácz P ál Miheller Mikl ós Horváth Hajnal Sz ékely Veronika Papp Di ána Czompa Attila Szij ártó Kl ára Werling Source Type: research
Antiplatelet agents for the treatment of adults with COVID-19
CONCLUSIONS: In people with confirmed or suspected COVID-19 and moderate to severe disease, we found moderate-certainty evidence that antiplatelets probably result in little to no difference in 28-day mortality, clinical worsening or improvement, but probably result in a slight reduction in thrombotic events. They probably increase the occurrence of major bleeding events. Low-certainty evidence suggests that antiplatelets may result in a slight increase in serious adverse events. In people with confirmed COVID-19 and mild symptoms, we found low-certainty evidence that antiplatelets may result in little to no difference in ...
Source: Pain Physician - July 25, 2023 Category: Anesthesiology Authors: Anna-Lena Fischer Sarah Messer Rachel Riera Ana Luiza C Martimbianco Miriam Stegemann Lise J Estcourt Stephanie Weibel Ina Monsef Marike Andreas Rafael L Pacheco Nicole Skoetz Source Type: research
An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases
Arch Microbiol. 2023 Jul 19;205(8):289. doi: 10.1007/s00203-023-03629-2.ABSTRACTVarious infectious agents affect human health via the oral entrance. The majority of pathogens lack approved vaccines. Oral vaccination is a convenient, safe and cost-effective approach with the potential of provoking mucosal and systemic immunity and maintaining individual satisfaction. However, vaccines should overcome the intricate environment of the gastrointestinal tract (GIT). Oral protein-based antigen vaccines (OPAVs) are easier to administer than injectable vaccines and do not require trained healthcare professionals. Additionally, the...
Source: Archives of Microbiology - July 19, 2023 Category: Microbiology Authors: Parisa Hashemi Shirin Mahmoodi Abdolmajid Ghasemian Source Type: research
Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population
CONCLUSIONS: Some adverse reactions to the COVID-19 vaccination are a greater risk of symptoms in the younger group, women, and participants with lower BMI. Care should be taken to monitor women, younger people, and individuals with a low body mass index for adverse effects after receiving the COVID-19 vaccination.PMID:37455163 | DOI:10.1016/j.vaccine.2023.04.053
Source: Vaccine - July 16, 2023 Category: Allergy & Immunology Authors: Xi Lu Shota Masuda Hasita Horlad Takahiko Katoh Source Type: research
Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination
CONCLUSION: Menstrual disturbances were common regardless of vaccination. We found increased risk of menstrual disturbances after vaccination, particularly for heavier bleeding than usual, prolonged bleeding, shorter interval between menstruations, and stronger period pain. In the future, menstrual characteristics should be included in vaccine trials.PMID:37451876 | DOI:10.1016/j.vaccine.2023.06.088
Source: Vaccine - July 14, 2023 Category: Allergy & Immunology Authors: Lill Trogstad Ida Laake Anna H Robertson Siri Mjaaland Ida H Caspersen Lene K Juvet Per Magnus Kristine Blix Berit Feiring Source Type: research
Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study
CONCLUSIONS: COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.PMID:37439342 | DOI:10.1097/CM9.0000000000002767
Source: Chinese Medical Journal - July 13, 2023 Category: General Medicine Authors: Xiaohan Wu Jingyi Li Jieling Ma Qianqian Liu Lan Wang Yongjian Zhu Yue Cui Anyi Wang Cenjin Wen Luhong Qiu Yinjian Yang Dan Lu Xiqi Xu Xijie Zhu Chunyan Cheng Duolao Wang Zhicheng Jing Source Type: research
Mpox: Rapid Evidence Review
Am Fam Physician. 2023 Jul;108(1):78-83.ABSTRACTMpox (formerly monkeypox) is a DNA virus of the Orthopoxvirus genus, similar to smallpox. Although mpox was endemic to the Democratic Republic of the Congo and parts of Africa, increasing numbers of cases were reported worldwide in 2022. More than 30,000 cases have been reported in the United States, and worldwide 98% of cases are found in men who have sex with men. Transmission is primarily through contact with skin lesions. The rash of mpox is often vesiculopustular and may be localized to the anogenital region or distributed on the face, trunk, limbs, palms, and soles. Two...
Source: Pain Physician - July 13, 2023 Category: Anesthesiology Authors: Aaron Saguil Lindy Krebs Ulyee Choe Source Type: research
Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study
CONCLUSIONS: COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.PMID:37439342 | DOI:10.1097/CM9.0000000000002767
Source: Chinese Medical Journal - July 13, 2023 Category: General Medicine Authors: Xiaohan Wu Jingyi Li Jieling Ma Qianqian Liu Lan Wang Yongjian Zhu Yue Cui Anyi Wang Cenjin Wen Luhong Qiu Yinjian Yang Dan Lu Xiqi Xu Xijie Zhu Chunyan Cheng Duolao Wang Zhicheng Jing Source Type: research
Mpox: Rapid Evidence Review
Am Fam Physician. 2023 Jul;108(1):78-83.ABSTRACTMpox (formerly monkeypox) is a DNA virus of the Orthopoxvirus genus, similar to smallpox. Although mpox was endemic to the Democratic Republic of the Congo and parts of Africa, increasing numbers of cases were reported worldwide in 2022. More than 30,000 cases have been reported in the United States, and worldwide 98% of cases are found in men who have sex with men. Transmission is primarily through contact with skin lesions. The rash of mpox is often vesiculopustular and may be localized to the anogenital region or distributed on the face, trunk, limbs, palms, and soles. Two...
Source: American Family Physician - July 13, 2023 Category: Primary Care Authors: Aaron Saguil Lindy Krebs Ulyee Choe Source Type: research
